Asthma Clinical Trial
Official title:
Housing, Heating and Health Study:a Randomised Community Trial
The Housing, Heating and Health Study has enrolled 409 households with ineffective heaters,
who have a child with asthma between 6 and 12 years.
In the winter of 2005, houses were insulated and baseline measures taken of indoor
temperatures, nitrogen dioxide, with more intensive indoor air quality monitoring in a
sub-sample of 33 homes.
Objective data are being collected on the household’s health and energy usage. The
households randomly assigned to the intervention group will have new heaters installed over
the summer.
Results will be available after the follow-up data collection in 2006.
1. Introduction New Zealand houses are relatively poorly constructed and maintained for
the temperate climate and most homes are heated to less than the WHO recommended
minimum winter temperature of 18°C. Excess winter mortality is comparable to the levels
in Portugal and Scotland. The Group’s previous Housing, Insulation and Health Study has
shown that insulating existing homes leads to a small but significant improvement in
health and energy consumption, but raised the question as to whether installing more
sustainable heating could increase these gains.
2. Study design
We have enrolled 409 households, who use either plug-in electric heaters or unflued gas
heating, and where there is a child with asthma, aged between 6 and 12 years. In the winter
of 2005, uninsulated houses were insulated and baseline measures taken of indoor
temperatures in the living room and the child’s bedroom, and levels of nitrogen dioxide.
Intensive monitoring of indoor air quality is being carried out in a sub-sample of 33 homes.
All members of the child’s family have filled out detailed questionnaires of their health
and the heads-of -household have completed a questionnaire on the characteristics of the
household’s energy usage. Objective measures are also being collected of the household’s
fuel bills, the child’s attendance at school and the family’s health care utilisation.
Households are randomised so that the intervention group will have their choice of new, more
efficient and sustainable heaters (heat pumps, wood pellet burners, or flued gas heaters)
that heat more of the house and which emit no internal emissions installed over the summer.
In the winter of 2006, follow-up measures will be taken and then the control households will
receive their choice of new heaters.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|